In clinical trials, Contract Research Organizations (CROs) often request upfront deposits or retainers for various expenses. These deposits, though common, are sometimes overlooked during contract negotiation. However, understanding and monitoring these amounts can save your company significant money and prevent cash from being unnecessarily tied up in the study. Large upfront payments are effectively interest-free loans to the CRO—it’s essential to manage them wisely.

Types of Upfront Payments

1. Direct Fees
   • Purpose: These upfronts are used to manage cash flow and float CROs for services they perform, usually under unit-based contracts where payment is made in arrears.
   • How it works: The deposit is held until the end of the study and credited back toward final invoices as services near completion. The amount of the deposit can fluctuate with changes in the trial budget when a change order is executed—additional upfronts may be requested when the budget grows. Similarly, reduced upfronts are possible when services are downscoped. If you have a change order where the services budget is reducing, you should request a reduction to the deposit as well!
   • Key Insight: Because these upfronts are used for a measurable purpose, to manage cash flow and float the CRO, it’s very easy to gauge the reasonability of the upfront being requested using a simple formula: (Total CRO Services Budget÷Contracted Days)×(1 month+payment terms)
     1. For a $1M budget over a 2 year timeline (730 days) with 30 day payment terms (60 day float), the required upfront should be $84,269.
2. Pass-Through Costs
   • Purpose: These upfronts cover start-up costs for third-party vendor contracts managed by the CRO and also as a float for all other pass through costs incurred by the CRO.
   • How it works: The portion of the deposit related to vendors is typically applied to the first few invoices pertaining to third-party vendors managed by the CRO. The remaining deposit pertaining to all other pass through costs are either:
     1. Held until the end of the study, similar to the Direct Fees upfront, or
     2. Amortized—with an equal portion drawn down and applied to each pass-through invoice over the study's duration.‍
   • Key Insight: Ensure that the portion of upfront payments related to third-party vendors is limited to true upfront costs. CROs, being risk-averse, may attempt to secure a larger portion of the third-party vendor budget in advance. However, most vendor agreements, such as EDC contracts, should be amortized over the full duration of the trial—paying the entire amount upfront is usually unnecessary.

1. Investigator Grants/Site Payments
   • Purpose: These rolling deposits cover patient fees and site-related administrative costs. 
   • How it works: Replenished on a typical cadence, usually quarterly, they ensure cash flow is maintained for site payments.
   • Key Insight: CROs may request inflated amounts to maintain a cash buffer for unforeseen site expenses. In more extreme cases, they might propose a blanket deposit without conducting a proper analysis to determine its reasonableness, leading to funds being held unnecessarily for months, or even over a year. It’s crucial to evaluate whether the requested upfronts are justified and align with projected enrollment and protocol costs.

Key Considerations

• When Are Upfronts Applied? Upfronts can be applied to initial invoices, held in escrow, or reserved for the trial’s conclusion.
• Communication with Vendors: Open communication ensures upfront management is transparent and aligned with expectations.
• Final Reconciliation: CROs should reconcile and apply any remaining upfront balances to final invoices before closing out the study. Tracking this ensures CROs remain accountable and don't profit from retained upfronts.

By thoroughly understanding and managing upfront payments, you can prevent unnecessary financial strain, ensuring your funds are allocated where they’re truly needed throughout the clinical trial.

‍